Chiung-Zuei Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Chiung-Zuei Chen has a total of 110 co-authors. Here are the top co-authors by number of shared publications:
Cheng-Hung Lee
Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, Medical College, National Cheng Kung University, Tainan, Taiwan
13 shared publications- Tzuen-Ren Hsiue
Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Medical College and Hospital, Tainan, Taiwan
13 shared publications Tzuen-Ren Hsiue
Division of Pulmonary Medicine, Department of Internal Medicine, College of Medicine, National Cheng Kung University Hospital, National Cheng Kung University, Tainan, Taiwan
11 shared publicationsHan-Yu Chang
Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, Medical College, National Cheng Kung University, Tainan, Taiwan
10 shared publications- Chien-Chung Lin
National Cheng Kung University
9 shared publications Sheng-Han Tsai
Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan
8 shared publications
Latest Publications
- Open Access
- 31 August 2026
- Published by Korean Academy of Rehabilitation Medicine in Annals of Rehabilitation Medicine
- Vol. 50 (4) , 265-277
Immediate Effects of Manual Muscle Stretching on Respiratory Capacity, Heart Rate Variability, and Diaphragmatic Function in Patients With COPD
Objective: To investigate the acute physiological responses following a single session of manual muscle stretching in patients with moderate to severe chronic obstructive pulmonary disease (COPD).Methods: A single-group pre–post design was used. Nineteen participants with moderate to severe COPD received one session of manual stretching, incorporating passive stretching and muscle energy techniques targeting the anterior scalene, upper trapezius, pectoralis, and diaphragm muscles. Primary outcomes included spirometry values, static lung volumes, heart rate variability (HRV), and diaphragmatic ultrasound. Secondary outcomes included respiratory muscle strength, upper limb flexibility, and symptom scores.Results: Following the intervention, participants exhibited a significant increase in expiratory reserve volume and diaphragmatic mobility, accompanied by a decrease in resting heart rate. HRV parameters (SDNN, RMSSD, LF, HF, and TP) showed significant changes following the intervention. Maximal inspiratory pressure increased from 76±47% to 85±51%, and maximal expiratory pressure increased from 55±30% to 67±34%, along with enhanced upper limb flexibility. Chest tightness, as assessed by the COPD Assessment Test, was significantly reduced. However, no significant changes were observed in spirometry values (FEV1, FVC, FEV1/FVC), other static lung volumes (TV, IRV, IC, VC), standardized HRV indices (HFnu, LFnu, LF/HF), or modified Medical Research Council scores.Conclusion: A single session of manual muscle stretching may be associated with immediate changes in respiratory mechanics, autonomic function, and symptom perception in patients with COPD.
- 31 August 2026
- Published by Korean Academy of Rehabilitation Medicine in Annals of Rehabilitation Medicine
- Vol. 50 (4) , 265-277
Open AccessImmediate Effects of Manual Muscle Stretching on Respiratory Capacity, Heart Rate Variability, and Diaphragmatic Function in Patients With COPD
Objective: To investigate the acute physiological responses following a single session of manual muscle stretching in patients with moderate to severe chronic obstructive pulmonary disease (COPD).Methods: A single-group pre–post design was used. Nineteen participants with moderate to severe COPD received one session of manual stretching, incorporating passive stretching and muscle energy techniques targeting the anterior scalene, upper trapezius, pectoralis, and diaphragm muscles. Primary outcomes included spirometry values, static lung volumes, heart rate variability (HRV), and diaphragmatic ultrasound. Secondary outcomes included respiratory muscle strength, upper limb flexibility, and symptom scores.Results: Following the intervention, participants exhibited a significant increase in expiratory reserve volume and diaphragmatic mobility, accompanied by a decrease in resting heart rate. HRV parameters (SDNN, RMSSD, LF, HF, and TP) showed significant changes following the intervention. Maximal inspiratory pressure increased from 76±47% to 85±51%, and maximal expiratory pressure increased from 55±30% to 67±34%, along with enhanced upper limb flexibility. Chest tightness, as assessed by the COPD Assessment Test, was significantly reduced. However, no significant changes were observed in spirometry values (FEV1, FVC, FEV1/FVC), other static lung volumes (TV, IRV, IC, VC), standardized HRV indices (HFnu, LFnu, LF/HF), or modified Medical Research Council scores.Conclusion: A single session of manual muscle stretching may be associated with immediate changes in respiratory mechanics, autonomic function, and symptom perception in patients with COPD.
- Open Access
- 1 January 2025
- Published by Wiley in Occupational Therapy International
- Vol. 2025 (1) , 3023322
Association Between Muscle Activity of Upper Limbs and Respiratory Parameters During Functional Performance in People With Chronic Obstructive Pulmonary Disease
Background: Few studies have examined the activity of the accessory inspiratory muscles as well as respiratory function simultaneously in individuals with chronic obstructive pulmonary disease (COPD) while performing activities of daily living (ADLs). This cross‐sectional study is aimed at understanding the differences in the demands for respiratory expenditure and activity of the upper limbs and accessory inspiratory muscles during functional performance in individuals with and without COPD. Methods: Thirteen patients with mild to moderate COPD and 10 healthy adults were enrolled. All participants were asked to complete the requested ADL tasks involving upper limb elevation while recording activities of muscles of the accessory inspiratory muscles, as well as respiratory expenditure via the Delsys Trigno electromyography and Ultima CardiO2 system, respectively. Results: Muscle activity of the pectoralis major (PM) in the COPD group was significantly higher than that in the non‐COPD group during washing both sides of the head ( p < 0.05) and storing 2‐ and 4‐kg objects on a shoulder‐height shelf ( p < 0.05). Ventilatory inefficiency and metabolic expenditure were significantly higher during the storage of objects at head height in the COPD group. A positive correlation was observed between sternocleidomastoid muscle activity and metabolic/ventilatory expenditure in the non‐COPD group. However, muscle activity of the upper trapezius was significantly correlated with metabolic/ventilatory expenditure in the COPD group. Higher PM muscle activity and ventilatory inefficiency in the COPD group were found during performing ADLs involving upper limb elevation. Conclusions: Individuals with COPD demonstrated increased accessory inspiratory muscle activity, reduced ventilatory efficiency, and higher metabolic expenditure during ADLs involving upper limb elevation compared to healthy controls. The PM in the COPD group was the major accessory inspiratory muscle for performing ADLs involving upper limb elevation. These findings could inform recommendations for individuals with COPD to adjust their strategies for upper limb elevation while performing ADLs. Training of the larger accessory inspiratory muscles in rehabilitation programs has also been considered to enhance ADL performance in individuals with COPD. Trial Registration: ClinicalTrials.gov identifier: NCT04146948
- 1 January 2025
- Published by Wiley in Occupational Therapy International
- Vol. 2025 (1) , 3023322
Open AccessAssociation Between Muscle Activity of Upper Limbs and Respiratory Parameters During Functional Performance in People With Chronic Obstructive Pulmonary Disease
Background: Few studies have examined the activity of the accessory inspiratory muscles as well as respiratory function simultaneously in individuals with chronic obstructive pulmonary disease (COPD) while performing activities of daily living (ADLs). This cross‐sectional study is aimed at understanding the differences in the demands for respiratory expenditure and activity of the upper limbs and accessory inspiratory muscles during functional performance in individuals with and without COPD. Methods: Thirteen patients with mild to moderate COPD and 10 healthy adults were enrolled. All participants were asked to complete the requested ADL tasks involving upper limb elevation while recording activities of muscles of the accessory inspiratory muscles, as well as respiratory expenditure via the Delsys Trigno electromyography and Ultima CardiO2 system, respectively. Results: Muscle activity of the pectoralis major (PM) in the COPD group was significantly higher than that in the non‐COPD group during washing both sides of the head ( p < 0.05) and storing 2‐ and 4‐kg objects on a shoulder‐height shelf ( p < 0.05). Ventilatory inefficiency and metabolic expenditure were significantly higher during the storage of objects at head height in the COPD group. A positive correlation was observed between sternocleidomastoid muscle activity and metabolic/ventilatory expenditure in the non‐COPD group. However, muscle activity of the upper trapezius was significantly correlated with metabolic/ventilatory expenditure in the COPD group. Higher PM muscle activity and ventilatory inefficiency in the COPD group were found during performing ADLs involving upper limb elevation. Conclusions: Individuals with COPD demonstrated increased accessory inspiratory muscle activity, reduced ventilatory efficiency, and higher metabolic expenditure during ADLs involving upper limb elevation compared to healthy controls. The PM in the COPD group was the major accessory inspiratory muscle for performing ADLs involving upper limb elevation. These findings could inform recommendations for individuals with COPD to adjust their strategies for upper limb elevation while performing ADLs. Training of the larger accessory inspiratory muscles in rehabilitation programs has also been considered to enhance ADL performance in individuals with COPD. Trial Registration: ClinicalTrials.gov identifier: NCT04146948
- Open Access
- 11 September 2024
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 22 (1) , 1-10
Dynamic changes in quality of life in older patients with chronic obstructive pulmonary disease: a 7-year follow up
Purposes: : Chronic obstructive pulmonary disease (COPD) is a major cause of the rapid decline of health-related quality of life (HRQoL), associated with accelerated frailty in older populations. This study aimed to analyse the long-term dynamic changes of HRQoL and the predictive factors for the rapid decline of HRQoL in older patients with COPD. Methods: Overall 244 patients with COPD, aged ≧ 65 years from one medical centre were enrolled between March 2012 and July 2020. Further, we prospectively assessed HRQoL scores with utility values, using EuroQol Five-Dimension (EQ-5D) questionnaires. Additionally, long-term dynamic changes in HRQoL were analysed using the Kernel smoothing method and examined the factors contributing to the deterioration of HRQoL using a linear mixed effects model. Results: Older patients with COPD with forced expiration volume (FEV1) < 50% of prediction entered the phase of rapid and continuous decline of HRQoL ~ 2 years after enrolment, but patients with FEV1 ≥ 50% of prediction without rapidly declined HRQoL during 7 years follow up. Therefore, FEV1 < 50% of prediction is a novel predictor for the rapid decline of HRQoL. The course of rapidly declining HRQoL occurred, initially in the usual activities and pain/discomfort domains, followed by the morbidity, self-care, and depression/anxiety domains ~ 2 and 4 years after enrolment, respectively. The mixed effects model indicated that both FEV1 < 50% of prediction and a history of severe acute exacerbation (SAE) requiring hospitalisation were contributing factors for deterioration in HRQoL . Conclusions: Both FEV1 < 50% of prediction and exacerbations requiring hospitalisation were contributing factors for the deterioration of HRQoL in long-term follow up. Additionally, FEV1 < 50% of prediction was a novel predictor for patients entering the phase of rapid decline of HRQoL.
- 11 September 2024
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 22 (1) , 1-10
Open AccessDynamic changes in quality of life in older patients with chronic obstructive pulmonary disease: a 7-year follow up
Purposes: : Chronic obstructive pulmonary disease (COPD) is a major cause of the rapid decline of health-related quality of life (HRQoL), associated with accelerated frailty in older populations. This study aimed to analyse the long-term dynamic changes of HRQoL and the predictive factors for the rapid decline of HRQoL in older patients with COPD. Methods: Overall 244 patients with COPD, aged ≧ 65 years from one medical centre were enrolled between March 2012 and July 2020. Further, we prospectively assessed HRQoL scores with utility values, using EuroQol Five-Dimension (EQ-5D) questionnaires. Additionally, long-term dynamic changes in HRQoL were analysed using the Kernel smoothing method and examined the factors contributing to the deterioration of HRQoL using a linear mixed effects model. Results: Older patients with COPD with forced expiration volume (FEV1) < 50% of prediction entered the phase of rapid and continuous decline of HRQoL ~ 2 years after enrolment, but patients with FEV1 ≥ 50% of prediction without rapidly declined HRQoL during 7 years follow up. Therefore, FEV1 < 50% of prediction is a novel predictor for the rapid decline of HRQoL. The course of rapidly declining HRQoL occurred, initially in the usual activities and pain/discomfort domains, followed by the morbidity, self-care, and depression/anxiety domains ~ 2 and 4 years after enrolment, respectively. The mixed effects model indicated that both FEV1 < 50% of prediction and a history of severe acute exacerbation (SAE) requiring hospitalisation were contributing factors for deterioration in HRQoL . Conclusions: Both FEV1 < 50% of prediction and exacerbations requiring hospitalisation were contributing factors for the deterioration of HRQoL in long-term follow up. Additionally, FEV1 < 50% of prediction was a novel predictor for patients entering the phase of rapid decline of HRQoL.
- Open Access
- 21 February 2024
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 11 (1) , e002037
Chronic obstructive pulmonary disease trajectory: severe exacerbations and dynamic change in health-related quality of life
Background The life trajectory of chronic obstructive pulmonary disease (COPD) remains unknown. Patients and methods We collected data from two populations. In the first cohort, we recruited 375 patients with COPD from our hospital, and 1440 repeated assessments of quality of life (QoL) using the European Quality of Life-5 Dimensions questionnaire from 2006 to 2020. We analysed their dynamic changes using the kernel-smoothing method. The second cohort comprised 27 437 patients from the National Health Insurance (NHI) dataset with their first severe acute exacerbations (AEs) requiring hospitalisation from 2008 to 2017 were analysed for their long-term course of AEs. We employed a Cox hazard model to analyse the predictors for mortality or AEs. Results Cohorts from our hospital and NHI were male predominant (93.6 and 83.5%, respectively). After the first severe AE, the course generally comprised three phases. The first was a 1-year period of elevated QoL, followed by a 2-year prolonged stable phase with a slowly declining QoL. After the second AE, the final phase was characterised by a rapid decline in QoL. For NHI cohort, 2712 died during the 11-year follow-up, the frequency of the first AE was approximately 5 per 10 000 per day. The median time from the first to the second AE was 3 years, which decreased to less than 6 and 3 months from 4th to 5th and 8th to 9th AE, respectively. The frequency of AE was increased 10-fold and 15-fold and risk of subsequent AE was increased 12-fold and 20-fold after the 6th and the 10th AE, relative to the first. Male gender, heart failure comorbidities were associated with the risk of subsequent AE and death. Conclusions The life trajectory of COPD includes the accelerated frailty phase, as well as elevated health and prolonged stable phase after the first AE.
- 21 February 2024
- Published by BMJ in BMJ Open Respiratory Research
- Vol. 11 (1) , e002037
Open AccessChronic obstructive pulmonary disease trajectory: severe exacerbations and dynamic change in health-related quality of life
Background The life trajectory of chronic obstructive pulmonary disease (COPD) remains unknown. Patients and methods We collected data from two populations. In the first cohort, we recruited 375 patients with COPD from our hospital, and 1440 repeated assessments of quality of life (QoL) using the European Quality of Life-5 Dimensions questionnaire from 2006 to 2020. We analysed their dynamic changes using the kernel-smoothing method. The second cohort comprised 27 437 patients from the National Health Insurance (NHI) dataset with their first severe acute exacerbations (AEs) requiring hospitalisation from 2008 to 2017 were analysed for their long-term course of AEs. We employed a Cox hazard model to analyse the predictors for mortality or AEs. Results Cohorts from our hospital and NHI were male predominant (93.6 and 83.5%, respectively). After the first severe AE, the course generally comprised three phases. The first was a 1-year period of elevated QoL, followed by a 2-year prolonged stable phase with a slowly declining QoL. After the second AE, the final phase was characterised by a rapid decline in QoL. For NHI cohort, 2712 died during the 11-year follow-up, the frequency of the first AE was approximately 5 per 10 000 per day. The median time from the first to the second AE was 3 years, which decreased to less than 6 and 3 months from 4th to 5th and 8th to 9th AE, respectively. The frequency of AE was increased 10-fold and 15-fold and risk of subsequent AE was increased 12-fold and 20-fold after the 6th and the 10th AE, relative to the first. Male gender, heart failure comorbidities were associated with the risk of subsequent AE and death. Conclusions The life trajectory of COPD includes the accelerated frailty phase, as well as elevated health and prolonged stable phase after the first AE.
- Top Cited PapersOpen Access
- 1 July 2023
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 18, 1511-1524
Current Progress of COPD Early Detection: Key Points and Novel Strategies
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, with approximately 70% to 80% of adults with COPD being undiagnosed. Patients with undiagnosed COPD are at increased risk of poor outcomes and a worsened quality of life, making early detection a crucial strategy to mitigate the impact of COPD and reduce the burden on healthcare systems. In the past decade, increased interest has been focused on the development of effective strategies and instrument for COPD early detection. However, identifying undiagnosed cases of COPD is still challenging. Both screening and case-finding approaches have been adopted to identify undiagnosed COPD, with case-finding being recommended by the 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline and the updated United States Preventive Services Task Force (USPTF) recommendation. Nonetheless, the approaches, criteria, and instruments used for early detection of COPD are varied. However, advances in the taxonomy and risk factors of COPD are continuously being investigated. It is important to continuously assess the current state of knowledge on COPD early detection, given the challenges associated with identifying undiagnosed COPD. This review aims to highlight recent advances in early detection of COPD. To discuss the current challenge and opportunity in COPD early detection, providing an overview of existing literature on COPD case-finding strategies, including the approaches, criteria for subjects, and instruments. The review also summarizes the current progress in COPD case-findings and proposes a COPD case-finding flowchart as an efficient method for identifying at risk COPD patients.
- 1 July 2023
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 18, 1511-1524
Top Cited PapersOpen AccessCurrent Progress of COPD Early Detection: Key Points and Novel Strategies
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, with approximately 70% to 80% of adults with COPD being undiagnosed. Patients with undiagnosed COPD are at increased risk of poor outcomes and a worsened quality of life, making early detection a crucial strategy to mitigate the impact of COPD and reduce the burden on healthcare systems. In the past decade, increased interest has been focused on the development of effective strategies and instrument for COPD early detection. However, identifying undiagnosed cases of COPD is still challenging. Both screening and case-finding approaches have been adopted to identify undiagnosed COPD, with case-finding being recommended by the 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guideline and the updated United States Preventive Services Task Force (USPTF) recommendation. Nonetheless, the approaches, criteria, and instruments used for early detection of COPD are varied. However, advances in the taxonomy and risk factors of COPD are continuously being investigated. It is important to continuously assess the current state of knowledge on COPD early detection, given the challenges associated with identifying undiagnosed COPD. This review aims to highlight recent advances in early detection of COPD. To discuss the current challenge and opportunity in COPD early detection, providing an overview of existing literature on COPD case-finding strategies, including the approaches, criteria for subjects, and instruments. The review also summarizes the current progress in COPD case-findings and proposes a COPD case-finding flowchart as an efficient method for identifying at risk COPD patients.
- Open Access
- 3 December 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Mapping algorithms for predicting EuroQol-5D-3L utilities from the assessment test of chronic obstructive pulmonary disease
To predict 3-Level version of European Quality of Life-5 Dimensions (EQ-5D-3L) questionnaire utility from the chronic obstructive pulmonary disease (COPD) assessment test (CAT), the study attempts to collect EQ-5D-3L and CAT data from COPD patients. Response mapping under a backward elimination procedure was used for EQ-5D score predictions from CAT. A multinomial logistic regression (MLR) model was used to identify the association between the score and the covariates. Afterwards, the predicted scores were transformed into the utility. The developed formula was compared with ordinary least squares (OLS) regression models and models using Mean Rank Method (MRM). The MLR models performed as well as other models according to mean absolute error (MAE) and root mean squared error (RMSE) evaluations. Besides, the overestimation for low utility patients (utility ≤ 0.6) and underestimation for near health (utility > 0.9) in the OLS method was improved through the means of the MLR model based on bubble chart analysis. In conclusion, response mapping with the MLR model led to performance comparable to the OLS and MRM models for predicting EQ-5D utility from CAT data. Additionally, the bubble charts analysis revealed that the model constructed in this study and MRM could be a better predictive model.
- 3 December 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-11
Open AccessMapping algorithms for predicting EuroQol-5D-3L utilities from the assessment test of chronic obstructive pulmonary disease
To predict 3-Level version of European Quality of Life-5 Dimensions (EQ-5D-3L) questionnaire utility from the chronic obstructive pulmonary disease (COPD) assessment test (CAT), the study attempts to collect EQ-5D-3L and CAT data from COPD patients. Response mapping under a backward elimination procedure was used for EQ-5D score predictions from CAT. A multinomial logistic regression (MLR) model was used to identify the association between the score and the covariates. Afterwards, the predicted scores were transformed into the utility. The developed formula was compared with ordinary least squares (OLS) regression models and models using Mean Rank Method (MRM). The MLR models performed as well as other models according to mean absolute error (MAE) and root mean squared error (RMSE) evaluations. Besides, the overestimation for low utility patients (utility ≤ 0.6) and underestimation for near health (utility > 0.9) in the OLS method was improved through the means of the MLR model based on bubble chart analysis. In conclusion, response mapping with the MLR model led to performance comparable to the OLS and MRM models for predicting EQ-5D utility from CAT data. Additionally, the bubble charts analysis revealed that the model constructed in this study and MRM could be a better predictive model.
- Open Access
- 9 March 2022
- Published by Springer Nature in Research Square
Mapping Algorithms For Predicting EQ-5D Utilities From The Assessment Test Of Chronic Obstructive Pulmonary Disease
Objectives: In order to predict the European Quality of Life-5 Dimensions three-Level (EQ-5D-3L) questionnaire utility from the chronic obstructive pulmonary disease (COPD) assessment test (CAT).Methods: The EQ-5D-3L and CAT data from 323 patients were collected. At first, response mapping under a backward elimination procedure was used for the EQ-5D score predictions from the CAT scores. A multinomial logistic regression (MLR) model was used to identify the association between the score and the covariates using a minimized quasi-information criterion (QIC). Afterwards, the predicted scores were transformed to the utility. Validation in the model selection depended on the mean absolute error (MAE) and the root mean squared error (RMSE) for the validation group. We also compared the developed formula with previous models based on an ordinary least squares (OLS) regression. Results: Using response mapping with the MLR model to predict EQ-5D utility from CAT in this study performed as well as OLS regression models in previous studies using MAE and RMSE evaluations (all MAEs ≤ 0.100). In addition, the overestimation for low utility patients (utility ≤ 0.6) and underestimation for near health (utility > 0.9) in previous developed OLS models was improved in this study using a bubble chart analysis. Conclusions: Response mapping with the MLR model led to performance comparable to that using the OLS model for predicting EQ-5D utility from CAT data. In addition, the bubble charts revealed that the model constructed in this study was a better predictive model than other alternatives.
- 9 March 2022
- Published by Springer Nature in Research Square
Open AccessMapping Algorithms For Predicting EQ-5D Utilities From The Assessment Test Of Chronic Obstructive Pulmonary Disease
Objectives: In order to predict the European Quality of Life-5 Dimensions three-Level (EQ-5D-3L) questionnaire utility from the chronic obstructive pulmonary disease (COPD) assessment test (CAT).Methods: The EQ-5D-3L and CAT data from 323 patients were collected. At first, response mapping under a backward elimination procedure was used for the EQ-5D score predictions from the CAT scores. A multinomial logistic regression (MLR) model was used to identify the association between the score and the covariates using a minimized quasi-information criterion (QIC). Afterwards, the predicted scores were transformed to the utility. Validation in the model selection depended on the mean absolute error (MAE) and the root mean squared error (RMSE) for the validation group. We also compared the developed formula with previous models based on an ordinary least squares (OLS) regression. Results: Using response mapping with the MLR model to predict EQ-5D utility from CAT in this study performed as well as OLS regression models in previous studies using MAE and RMSE evaluations (all MAEs ≤ 0.100). In addition, the overestimation for low utility patients (utility ≤ 0.6) and underestimation for near health (utility > 0.9) in previous developed OLS models was improved in this study using a bubble chart analysis. Conclusions: Response mapping with the MLR model led to performance comparable to that using the OLS model for predicting EQ-5D utility from CAT data. In addition, the bubble charts revealed that the model constructed in this study was a better predictive model than other alternatives.
- Open Access
- 13 January 2022
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 32 (1) , 1-6
Development and validation of a prediction index for recent mortality in advanced COPD patients
The primary barrier to initiating palliative care for advanced COPD patients is the unpredictable course of the disease. We enroll 752 COPD patients into the study and validate the prediction tools for 1-year mortality using the current guidelines for palliative care. We also develop a composite prediction index for 1-year mortality and validate it in another cohort of 342 patients. Using the current prognostic models for recent mortality in palliative care, the best area under the curve (AUC) for predicting mortality is 0.68. Using the Modified Medical Research Council dyspnea score and oxygen saturation to define the combined dyspnea and oxygenation (DO) index, we find that the AUC of the DO index is 0.84 for predicting mortality in the validated cohort. Predictions of 1-year mortality based on the current palliative care guideline for COPD patients are poor. The DO index exhibits better predictive ability than other models in the study.
- 13 January 2022
- Published by Springer Nature in npj Primary Care Respiratory Medicine
- Vol. 32 (1) , 1-6
Open AccessDevelopment and validation of a prediction index for recent mortality in advanced COPD patients
The primary barrier to initiating palliative care for advanced COPD patients is the unpredictable course of the disease. We enroll 752 COPD patients into the study and validate the prediction tools for 1-year mortality using the current guidelines for palliative care. We also develop a composite prediction index for 1-year mortality and validate it in another cohort of 342 patients. Using the current prognostic models for recent mortality in palliative care, the best area under the curve (AUC) for predicting mortality is 0.68. Using the Modified Medical Research Council dyspnea score and oxygen saturation to define the combined dyspnea and oxygenation (DO) index, we find that the AUC of the DO index is 0.84 for predicting mortality in the validated cohort. Predictions of 1-year mortality based on the current palliative care guideline for COPD patients are poor. The DO index exhibits better predictive ability than other models in the study.
- Open Access
- 1 December 2021
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 16, 3405-3415
Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
Background and Aim: Chronic obstructive pulmonary disease (COPD) is frequently underdiagnosed because of the unavailability of spirometers, especially in resource-limited outpatient settings. This study provides real-world evidence to identify optimal approaches for COPD case finding in outpatient settings. Methods: This retrospective study enrolled individuals who were at risk of COPD (age ≥ 40 years, ≥ 10 pack-years, and ≥ 1 respiratory symptom). Eligible participants were examined using various COPD case-finding tools, namely the COPD Population Screener (COPD-PS) questionnaire, a COPD prediction (PCOPD) model, and a microspirometer, Spirobank Smart; subsequently, the participants underwent confirmatory spirometry. The definition and confirmation of COPD were based on conventional spirometry. Receiver operating characteristic curve (ROC), area under the curve (AUC), and decision curve analyses were conducted, and a clinical impact curve was constructed. Results: In total, 385 participants took part in the study [284 without COPD (73.77%) and 101 with COPD (26.23%)]. The microspirometer exhibited a higher AUC value than did the COPD-PS questionnaire and the PCOPD model. The AUC for microspirometry was 0.908 (95% confidence interval [CI] = 0.87– 0.95), that for the PCOPD model was 0.788 (95% CI = 0.74– 0.84), and that for the COPD-PS questionnaire was 0.726 (95% CI = 0.67– 0.78). Decision and clinical impact curve analyses revealed that a microspirometry-derived FEV1/FVC ratio of < 74% had superior clinical utility to the other measurement tools. Conclusion: The PCOPD model and COPD-PS questionnaire were useful for identifying symptomatic patients likely to have COPD, but microspirometry was more accurate and had higher clinical utility. This study provides real-world evidence to identify optimal practices for COPD case finding; such practices ensure that physicians have convenient access to up-to-date evidence when they encounter a symptomatic patient likely to have COPD.
- 1 December 2021
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 16, 3405-3415
Open AccessPerformance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
Background and Aim: Chronic obstructive pulmonary disease (COPD) is frequently underdiagnosed because of the unavailability of spirometers, especially in resource-limited outpatient settings. This study provides real-world evidence to identify optimal approaches for COPD case finding in outpatient settings. Methods: This retrospective study enrolled individuals who were at risk of COPD (age ≥ 40 years, ≥ 10 pack-years, and ≥ 1 respiratory symptom). Eligible participants were examined using various COPD case-finding tools, namely the COPD Population Screener (COPD-PS) questionnaire, a COPD prediction (PCOPD) model, and a microspirometer, Spirobank Smart; subsequently, the participants underwent confirmatory spirometry. The definition and confirmation of COPD were based on conventional spirometry. Receiver operating characteristic curve (ROC), area under the curve (AUC), and decision curve analyses were conducted, and a clinical impact curve was constructed. Results: In total, 385 participants took part in the study [284 without COPD (73.77%) and 101 with COPD (26.23%)]. The microspirometer exhibited a higher AUC value than did the COPD-PS questionnaire and the PCOPD model. The AUC for microspirometry was 0.908 (95% confidence interval [CI] = 0.87– 0.95), that for the PCOPD model was 0.788 (95% CI = 0.74– 0.84), and that for the COPD-PS questionnaire was 0.726 (95% CI = 0.67– 0.78). Decision and clinical impact curve analyses revealed that a microspirometry-derived FEV1/FVC ratio of < 74% had superior clinical utility to the other measurement tools. Conclusion: The PCOPD model and COPD-PS questionnaire were useful for identifying symptomatic patients likely to have COPD, but microspirometry was more accurate and had higher clinical utility. This study provides real-world evidence to identify optimal practices for COPD case finding; such practices ensure that physicians have convenient access to up-to-date evidence when they encounter a symptomatic patient likely to have COPD.
- Open Access
- 1 October 2021
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 16, 2869-2881
Effectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. It has also imposed a substantial economic and social burden on the health care system. In Taiwan, a nationwide COPD pay-for-performance (P4P) program was designed to improve the quality of COPD-related care by introducing financial incentives for health care providers and employing a multidisciplinary team to deliver guideline-based, integrated care for patients with COPD, reducing adverse outcomes, especially COPD exacerbation. However, the results of a survey of the effectiveness of the pay-for-performance program in COPD management were inconclusive. To address this knowledge gap, this study evaluated the effectiveness of the COPD P4P program in Taiwan. Methods: This retrospective cohort study used data from Taiwan’s National Health Insurance claims database and nationwide COPD P4P enrollment program records from June 2016 to December 2018. Patients with COPD were classified into P4P and non-P4P groups. Patients in the P4P group were matched at a ratio of 1:1 based on age, gender, region, accreditation level, Charlson Comorbidity Index (CCI), and inhaled medication prescription type to create the non-P4P group. A difference-in-difference analysis was used to evaluate the influence of the P4P program on the likelihood of COPD exacerbation, namely COPD-related emergency department (ED) visit, intensive care unit (ICU) admission, or hospitalization. Results: The final sample of 14,288 patients comprised 7144 in each of the P4P and non-P4P groups. The prevalence of COPD-related ED visits, ICU admissions, and hospitalizations was higher in the P4P group than in the non-P4P group 1 year before enrollment. After enrollment, the P4P group exhibited a greater decrease in the prevalence of COPD-related ED visits and hospitalizations than the non-P4P group (ED visit: − 2.98%, p< 0.05, 95% confidence interval [CI]: − 0.277 to − 0.086; hospitalization: − 1.62%, p< 0.05, 95% CI: − 0.232 to − 0.020), whereas no significant difference was observed between the groups in terms of the changes in the prevalence of COPD-related ICU admissions. Conclusion: The COPD P4P program exerted a positive net effect on reducing the likelihood of COPD exacerbation, namely COPD-related ED visits and hospitalizations. Future studies should examine the long-term cost-effectiveness of the COPD P4P program.
- 1 October 2021
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 16, 2869-2881
Open AccessEffectiveness of Nationwide COPD Pay-for-Performance Program on COPD Exacerbations in Taiwan
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. It has also imposed a substantial economic and social burden on the health care system. In Taiwan, a nationwide COPD pay-for-performance (P4P) program was designed to improve the quality of COPD-related care by introducing financial incentives for health care providers and employing a multidisciplinary team to deliver guideline-based, integrated care for patients with COPD, reducing adverse outcomes, especially COPD exacerbation. However, the results of a survey of the effectiveness of the pay-for-performance program in COPD management were inconclusive. To address this knowledge gap, this study evaluated the effectiveness of the COPD P4P program in Taiwan. Methods: This retrospective cohort study used data from Taiwan’s National Health Insurance claims database and nationwide COPD P4P enrollment program records from June 2016 to December 2018. Patients with COPD were classified into P4P and non-P4P groups. Patients in the P4P group were matched at a ratio of 1:1 based on age, gender, region, accreditation level, Charlson Comorbidity Index (CCI), and inhaled medication prescription type to create the non-P4P group. A difference-in-difference analysis was used to evaluate the influence of the P4P program on the likelihood of COPD exacerbation, namely COPD-related emergency department (ED) visit, intensive care unit (ICU) admission, or hospitalization. Results: The final sample of 14,288 patients comprised 7144 in each of the P4P and non-P4P groups. The prevalence of COPD-related ED visits, ICU admissions, and hospitalizations was higher in the P4P group than in the non-P4P group 1 year before enrollment. After enrollment, the P4P group exhibited a greater decrease in the prevalence of COPD-related ED visits and hospitalizations than the non-P4P group (ED visit: − 2.98%, p< 0.05, 95% confidence interval [CI]: − 0.277 to − 0.086; hospitalization: − 1.62%, p< 0.05, 95% CI: − 0.232 to − 0.020), whereas no significant difference was observed between the groups in terms of the changes in the prevalence of COPD-related ICU admissions. Conclusion: The COPD P4P program exerted a positive net effect on reducing the likelihood of COPD exacerbation, namely COPD-related ED visits and hospitalizations. Future studies should examine the long-term cost-effectiveness of the COPD P4P program.